Skip to main content
Fig. 5 | BMC Veterinary Research

Fig. 5

From: Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker

Fig. 5

Analysis of serum TK1 levels in normal and diseased cats. A Comparison of serum TK1 levels in healthy group (n = 40) and cats with malignant diseases (lymphoma n = 12, and solid tumor n = 9); B ROC (receiver operating characteristic) analysis of serum TK1 levels in lymphoma group; C ROC analysis of serum TK1 levels in the solid tumor group; D Serum TK1 levels in 3 patients following treatment. The sampling point corresponded to the time when the serum sample was taken during a veterinary visit and a new treatment dose was given if needed. The time interval between each sampling point varied from 1 to 3 weeks

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us